NoviaHealth LLC Announced as a Spin-Off from Synbiotic Health; New Company Will Focus on Commercialization of Probiotics and Other Dietary Supplements

/in /by

NoviaHealth will support the market from Ideation to Launch with novel product
concepts, turn-key CDMO services and a broad probiotic portfolio

NoviaHealth will operate from a new facility of labs, offices and manufacturing
space in Madison, Wisconsin

Synbiotic Health to remain operational as a separate company providing
microbiome R&D; NoviaHealth will have exclusive rights to commercialize new
discoveries

Madison, WI | October 18th, 2023: NoviaHealth, a new company dedicated to the commercialization of advanced probiotic ingredients for improved health, has been launched as a spin-off from Synbiotic Health, a market leader in the discovery of probiotic ingredients. As a new and independent company, NoviaHealth LLC will provide probiotic concentrates, custom probiotic blends, and turn-key contract development and manufacturing services to the dietary supplement market.

NoviaHealth will operate from laboratories, offices, and a new manufacturing facility in Madison, Wisconsin, that is scheduled to open in the second quarter of 2024. Synbiotic Health will continue to function as an independent company providing microbiome R&D services, and NoviaHealth will have the exclusive right to commercialize future Synbiotic Health discoveries, including new strains and other intellectual property.

NoviaHealth was created with the mission to deliver complete solutions to the dietary supplement market, from ideation to launch, in a service-first culture. The new company will provide the market with benefits and services that CPG brands have been asking for, including product concept ideation, co-development, custom formulations, and low minimum order quantities, all within a culture of operational transparency.

In addition to offering all the capabilities of a leading contract development and manufacturing organization (CDMO), NoviaHealth will continue to provide the ecologically advanced probiotics iVS-1® and iVE-15®, the legacy products of Synbiotic Health.
NoviaHealth will also offer additional clinically documented and undocumented probiotic strains, as well as new probiotic solutions developed by the Madison R&D team. Targeted health areas for the full NoviaHealth strain portfolio include solutions for digestive,
women’s, cognitive, children’s, early life, immunity, healthy aging, and metabolic health.

NoviaHealth will be led by a senior management team comprised of three highly experienced executives. Tim Brummels, President and CEO of NoviaHealth, has more than thirty years of senior management experience, highlighted by leadership positions at Prenexus Health and Synbiotic Health. Steve Prescott, Chief Commercial Officer, has held senior positions at ProBiotix Health, Probi AB, and DuPont. Kevin Hooper, VP Sales & Marketing, brings account management and marketing expertise garnered at IFF, DuPont and Ready Nutrition. Together, they understand the dynamics of the current marketplace and are building an organization that’s ready to meet the evolving demands of the industry.

Tim Brummels, President and CEO of NoviaHealth, stated “There’s a reason “Novia” is part of our name. It references our
new way of thinking and a new way of operating. Novia is derived from the Latin word “novus”, meaning new, which
reflects our constant pursuit of new ideas and innovative solutions. The creation of NoviaHealth represents our evolution
to meet the needs of the market. As an innovative, boutique CDMO, we will cater to our customers with the services they need most: complete support from ideation to launch, a high-performing portfolio of probiotics, and a very
strong commitment to personalized service.”

About NoviaHealth
NoviaHealth LLC was founded in 2023 as a spin-off from Synbiotic Health and was created to be the ideation to launch partner company for health innovator brands. The company provides turn-key contract development and manufacturing services to the health and nutrition markets, along with commercial scale probiotic concentrates and custom blends. These include the ecologically advanced probiotics iVS-1® and iVE-15®, which are legacy products of Synbiotic Health, as well as a diverse range of clinically
documented and undocumented strain genera and species. NoviaHealth’s value proposition focuses on delivering the benefits that health innovator brands have been asking for in a service-first culture, including product concept ideation, co-development, custom formulations, and low minimum order quantities , all within a culture of operational transparency.
www.noviahealth.com

About Synbiotic Health
Synbiotic Health was founded in 2018 by four microbiome research scientists to develop targeted microbiome ingredients to support health. The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s
approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health. The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health Discovers New Potential Health Benefits for its Flagship Ecologically Advanced Probiotic® Strain B. adolescentis iVS-1®

/in , /by
Read more

Nebraska Governor Pete Ricketts Presents Synbiotic Health with the 2022 Governor’s Bioscience Award

/in /by

Synbiotic Health is delighted to announce that its team has received the Bio Nebraska 2022 Governor’s Bioscience Award, which recognizes companies making significant contributions to the Nebraska bioscience industry. CEO Tim Brummels received this prestigious award in a presentation ceremony at Bio Nebraska’s Annual Meeting on Oct. 20, 2022, in Omaha, Nebraska.

Governor Pete Ricketts, who presented the award to Synbiotic Health, highlighted the company’s solid science: “The University of Nebraska scientists who co-founded Synbiotic Health have dedicated their careers to better understanding microbiology and food science. They’ve drawn on insights gleaned through decades of research to develop breakthrough products clinically proven to improve digestive health.”

The award’s selection criteria range from conducting innovative research to product development to investment that grows the bioscience community in Nebraska. The recipient is selected based on input from Bio Nebraska Board of Directors and the Nebraska Department of Economic Development, as well as conversations with state leaders. Synbiotic Health has been a member of Bio Nebraska since 2019.

See the official press release here.

Synbiotic Health Team Welcomes Mallory Van Haute as Lab Scientist

/in /by

With a decade’s experience in food and microbiology, Van Haute will help execute on Synbiotic Health’s ambitious R&D program

LINCOLN, Neb.  – October 1, 2021 – Microbiome-based ingredient company Synbiotic Health welcomes team member Mallory Van Haute this week in the role of Laboratory Scientist. Van Haute brings ten years’ scientific experience in food and gastrointestinal microbiology, having worked in multiple academic laboratories at University of Nebraska – Lincoln. She has been Research Manager at the Nebraska Food for Health Center and has more than a dozen peer-reviewed publications.

In the role of Scientist at Synbiotic Health, Van Haute will report to CSO Dr. Zac Lewis and carry out research and development activities in the company’s innovation pipeline. She will lead lab work and bioinformatic projects to guide product development and deliver new health-promoting ingredients to market. She holds an M.S. in Food Science & Technology from University of Nebraska – Lincoln and is nearing completion of her Ph.D.

“Mallory has worked closely with some of our founders for many years, and brings exceptional knowledge and experience in diet-microbiome interactions to our team” says CSO Dr. Zac Lewis. “We could not be happier that she is joining us. Her presence increases our capacity to discover new ecologically advanced probiotic strains, design intelligently paired synbiotics, and rationally target the aspects of human health where our product development approach will yield superior results for consumers.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop targeted microbiome ingredients to support health. Based on over 10 years of research, Synbiotic Health will develop and commercialize Ecologically Advanced Probiotics™ as well as rationally designed Synergistic Synbiotics™.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic™ – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Kristina Campbell

Kristina@synbiotichealth.com

Thomas Auchtung, PhD, joins Synbiotic Health as Lab Manager

/in /by

Experienced microbiologist to manage the company’s microbiome-focused research and development platform

LINCOLN, Neb.  – August 3, 2021 – Microbiome-based ingredient company Synbiotic Health is pleased to welcome Dr. Thomas Auchtung to the team in the key role of Laboratory Manager. Auchtung comes to Synbiotic Health with a wealth of microbiology research experience and scientific talent. He holds a PhD from Harvard University and joins the company after spending three years as Research Assistant Professor in the Department of Food Science and Technology at University of Nebraska-Lincoln.

Auchtung will manage internal laboratory operations and external testing to execute on the company’s product development and improvement strategy, as the company prepares to release its first commercially available ingredient, the iVS-1 Advanced Probiotic™ strain. The author of 19 peer-reviewed publications, Auchtung has previously worked in the labs of Joseph Petrosino at Baylor College of Medicine, Robert Britton at Michigan State University, Colleen Cavanaugh at Harvard University, Alan Grossman at MIT, and Robert Hausinger at Michigan State University.

“Tommy brings an impressive breadth of scientific experience from working in leading academic labs,” says Zac Lewis, CSO of Synbiotic Health. “We are delighted to have him join our growing company to help develop our unique portfolio of ecologically-designed ingredients. Having him lead our internal discovery and bench research activities will let us continue to bring truly innovative and disruptive offerings to the market for the long term. This capability will help position us as the leading science-based and data-driven strain provider in the probiotic industry; delivering demonstrably superior ecology-based technology as envisioned by our founders.”

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize Advanced Probiotics™ as well as Synergistic Synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic™ – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Kristina Campbell

Kristina@synbiotichealth.com

Faculty-Led Startup Takes Aim at Improving Gut Health

/in /by

This is a press release from NUtech Ventures, first published on the website of University of Nebraska-Lincoln

Nebraska faculty have founded a university spin-off company, Synbiotic Health, to develop a combination of beneficial gut bacteria and the fuel that feeds them.

A synbiotic, the company’s namesake, refers to the mixture of beneficial bacteria and fiber-like fuel that may be more effective at delivering health benefits when paired together. Working with NUtech Ventures, the university’s technology commercialization affiliate, the startup company has licensed its first synbiotic strains and plans to begin human clinical trials next year.

The company’s founding members include Nebraska’s Bob Hutkins, Andy Benson and Tom Burkey, as well as the University of Alberta’s Jens Walters and CEO Tim Brummels. The team formed Synbiotic Health with the goal of commercializing synbiotic combinations as ingredients for food and beverage companies.

The Nebraska researchers have long been studying how fiber-like prebiotics can support the growth of probiotics, beneficial bacteria that reside in the gastrointestinal tract. Their research also focuses on pairing the right prebiotic with the right probiotic, which may help good bacteria stick around long enough to have health benefits.

“We’re excited to provide a scientific foundation that supports the commercialization of safe, effective synbiotics,” Brummels said. “The gut microbiome, and its impact on human health, is a key product-development platform for a number of leading nutritional companies.”

According to food scientist Andy Benson, the partnership with Synbiotic Health is also an important achievement for the Nebraska Food for Health Center. The center focuses on developing foods with proven health benefits, particularly those that affect the human gut microbiome.

“This partnership demonstrates the center’s commitment to translating and commercializing research-based products,” said Benson, presidential chair and center director. “These synbiotics are a rapidly emerging class of ‘next generation’ probiotics that can ultimately improve human and animal health.”

Synbiotic Health Opens Laboratory at University of Nebraska

/in /by

Synbiotic Health announces it has signed a lease on a laboratory space at the Biotech Connector space located at the NUtech Innovation Center on the University of Nebraska’s Lincoln campus. The new lab will allow the company’s science team to continue its efforts to advance the development of a unique class of synergistic synbiotics.

The company’s inaugural synbiotic nutritional ingredient is forthcoming in 2020.

Synbiotic Health Scientists Publish Scientific Paper on Unique Synbiotic Formulation Strategy

/in /by

University of Nebraska professor and Synbiotic Health co-founding scientist Dr. Robert Hutkins is leading the development of a unique strategy to formulate synergistic synbiotics—and this innovative technique was recently published in an academic paper in the American Society for Microbiology Journal. The paper, entitled “An In Vitro Enrichment Strategy for Formulating Synergistic Synbiotics”, is co-authored by Hutkins along with Car Reen Kok, David Fabian Gomez Quintero, Clement Niyirora, Devin Rose, and Amanda Li.

“To date, demonstrating synergistic effects of probiotic and prebiotic ingredients has been scientifically challenging,”— says Tim Brummels, CEO of Synbiotic Health. “This publication pioneers and approach that shows it’s possible to improve on the synbiotic products currently available on the market. We look forward to continuing our scientific work, creating unique synbiotic formulations to support human health.”

The paper can be found here.

Synbiotic Health Establishes Headquarters at the Nebraska Innovation Campus

/in /by

Synbiotic Health has opened an office at Nebraska Innovation Campus (NIC), adjacent to the University of Nebraska-Lincoln. NIC is a public/private research campus connected with the University of Nebraska—designed to connect the talents of experts, industry, and the university to create a culture of collaboration and innovation.

The office will serve as the company headquarters as its science team continues its R&D efforts on a new class of synergistic synbiotics.

Synbiotic Health Appoints Tim Brummels as President and CEO

/in /by

The Synbiotic Health team is pleased to announce that Tim Brummels has been appointed Chair of the Board, CEO, and President. Brummels is a 30-year entrepreneur, executive officer, board member, and investor for natural health ingredient companies.

Brummels and has worked with companies that range from start-ups to Fortune 500 companies, including his own consultancy, Edgewater Company, ConAgra Foods and Berkshire Hathaway Homestate Company. Brummels is also a co-founder and current board member of Prenexus Health, Inc., having previously served the company as CEO and President. His approach to achieving market success centers around strategic planning, capitalization, financing and measurable execution plans.

Brummels says, “As we move into an era of learning more about the human microbiome, new opportunities are emerging for modulating the gut microbiome to achieve better health. I look forward to working with this world-leading team of scientific experts who are pioneering new approaches and products.” See here for more on Tim Brummels.